Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21558517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
Condition: Acute ST Elevation Myocardial Infarction
Interventions: Drug: Epoietin Alfa;   Drug: Placebo

Indicates status has not been verified in more than two years